I. Lundberg

发表

Autoantibody profiles in the sera of European patients with myositis

D. Isenberg, B. Engelen, J. Vencovský, 2001, Annals of the rheumatic diseases.

Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies

L. Padyukov, L. Pleštilová, J. Vencovský, 2016, Scandinavian journal of immunology.

Aerobic capacity correlates to self-assessed physical function but not to overall disease activity or organ damage in women with systemic lupus erythematosus with low-to-moderate disease activity and organ damage

C. Boström, C. Opava, E. Jansson, 2008, Lupus.

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

G. Serratrice, D. Isenberg, J. Callen, 2004, Rheumatology.

Evaluation of risk factors and biomarkers related to arterial and venous thrombotic events in idiopathic inflammatory myopathies

M. Holmqvist, A. Notarnicola, I. Lundberg, 2021, Scandinavian journal of rheumatology.

Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?

I. Loell, I. Lundberg, 2011, Journal of internal medicine.

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

J. Lamb, C. Saris, B. V. van Engelen, 2017, Annals of the rheumatic diseases.

Polymyositis: An overdiagnosed entity

A. Pestronk, D. Isenberg, B. Engelen, 2004, Neurology.

Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study

L. Alfredsson, L. Padyukov, M. Remáková, 2011, Annals of the rheumatic diseases.

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen

J. Vencovský, B. V. van Engelen, A. Doria, 2006 .

Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.

I. Lundberg, H. Alexanderson, M. Patarroyo, 2000, Arthritis and rheumatism.

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

B. Engelen, J. Vencovský, B. V. van Engelen, 2006, Annals of the rheumatic diseases.

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 b antigen

A. Doria, G. Hengstman, H. Seelig, 2005 .

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

G. Shaddick, J. Vencovský, R. Cooper, 2019, Journal of autoimmunity.

Diagnosis and classification of idiopathic inflammatory myopathies

M. Bottai, F. Miller, I. Lundberg, 2016, Journal of internal medicine.

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.

D. Isenberg, V. Farewell, J. Vencovský, 2001, Rheumatology.

Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus

G. Gard, C. Boström, I. Lundberg, 2008, Scandinavian journal of rheumatology.

Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis

I. Lundberg, M. Dastmalchi, G. Tornling, 2004, Annals of the rheumatic diseases.

The autoimmune spectrum of myasthenia gravis: a Swedish population‐based study

F. Piehl, L. Hammarström, R. Pirskanen, 2015, Journal of internal medicine.

Effects of a one-year physical activity programme for women with systemic lupus erythematosus – a randomized controlled study

C. Boström, C. Opava, E. Jansson, 2016, Lupus.

KL‐6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis

I. Lundberg, S. B. Helmers, I. Lundberg, 2012, Journal of internal medicine.

SAT0436 Abatacept in the Treatment of Adult Dermatomyositis and Polymyositis: Artemis, a Randomized, Treatment Delayed-Start Trial

H. Mann, J. Vencovský, P. Gordon, 2015 .

POS0839 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE EFFICACY AND SAFETY OF SC ABATACEPT IN ADULTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY

V. Werth, I. Lundberg, A. Shaibani, 2022, Annals of the Rheumatic Diseases.

Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies

I. Lundberg, F. Iannone, G. Lapadula, 2015, Scandinavian journal of rheumatology.

Evaluation of an individually tailored smoking-cessation intervention for patients with rheumatoid arthritis in an outpatient clinic.

S. Saevarsdottir, S. Pettersson, I. Demmelmaier, 2023, Scandinavian journal of rheumatology.

Cardiac Abnormalities in Adult Patients With Polymyositis or Dermatomyositis as Assessed by Noninvasive Modalities

S. Kay, J. Simonsen, L. Dreyer, 2016, Arthritis care & research.

New ways to subclassify patients with myositis

I. Lundberg, 2016, Journal of internal medicine.

Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies

P. Gregersen, J. Lamb, T. Radstake, 2014, Annals of the rheumatic diseases.

Determination of the minimal clinically important difference for seven measures of fatigue in Swedish patients with systemic lupus erythematosus

J. Pouchot, S. Pettersson, E. Welin Henriksson, 2015, Scandinavian journal of rheumatology.

Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey

C. Fiehn, U. Schneider, H. Chinoy, 2023, Rheumatology International.

Polymyositis: An overdiagnosed entity

A. Pestronk, D. Isenberg, B. Engelen, 2004, Neurology.

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen.

J. Vencovský, B. V. van Engelen, A. Doria, 2006, Annals of the rheumatic diseases.

Clinical and epidemiological research

L. Alfredsson, L. Padyukov, M. Remáková, 2012 .